scholarly journals Adherence, persistence, glycaemic control and costs among patients with type 2 diabetes initiating dulaglutide compared with liraglutide or exenatide once weekly at 12‐month follow‐up in a real‐world setting in the United States

2019 ◽  
Vol 21 (4) ◽  
pp. 920-929 ◽  
Author(s):  
Reema Mody ◽  
Qing Huang ◽  
Maria Yu ◽  
Ruizhi Zhao ◽  
Hiren Patel ◽  
...  
Keyword(s):  
United States ◽  
Type 2 Diabetes ◽  
Glycaemic Control ◽  
Real World ◽  
The United States ◽  
Real World Setting

scholarly journals Effectiveness and Tolerability of Therapy With Once-Weekly Exenatide Versus Basal Insulin Among Injectable-Naive Patients With Type 2 Diabetes in a Real-World Setting in the United States

2018 ◽  
Vol 31 (2) ◽  
pp. 129-137 ◽  
Author(s):  
Anita M. Loughlin ◽  
Qing Qiao ◽  
Anthony P. Nunes ◽  
Stephen M. Ezzy ◽  
Laura Yochum ◽  
...  
Keyword(s):  
United States ◽  
Type 2 Diabetes ◽  
Real World ◽  
Basal Insulin ◽  
The United States ◽  
Real World Setting

Real-World Comparative Effectiveness of Canagliflozin Versus Empagliflozin and Dapagliflozin in Patients with Type 2 Diabetes in the United States

2020 ◽  
Author(s):  
Lawrence Blonde ◽  
Charmi Patel ◽  
Bingcao Wu ◽  
Yen-Wen Chen ◽  
Christopher D. Pericone ◽  
...  
Keyword(s):  
United States ◽  
Type 2 Diabetes ◽  
Real World ◽  
Comparative Effectiveness ◽  
The United States

scholarly journals Glycaemic control after treatment intensification in patients with type 2 diabetes uncontrolled on two or more non‐insulin antidiabetic drugs in a real‐world setting

2019 ◽  
Vol 21 (6) ◽  
pp. 1373-1380 ◽  
Author(s):  
Silvia Canivell ◽  
Manel Mata‐Cases ◽  
Jordi Real ◽  
Josep Franch‐Nadal ◽  
Bogdan Vlacho ◽  
...  
Keyword(s):  
Type 2 Diabetes ◽  
Glycaemic Control ◽  
Real World ◽  
Antidiabetic Drugs ◽  
Treatment Intensification ◽  
Real World Setting
Sign in / Sign up

Export Citation Format

Share Document